3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
14
Prostatic Neoplasms
4
Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Precancerous Conditions
2
Peripheral Nervous System Diseases
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Breast Carcinoma In Situ
2
Weight Loss
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Polycystic Ovary Syndrome
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Interventions
Colonoscopy
4
Narrow Band Imaging
2
eicosapentaenoic acid ethyl ester
1
Ursodeoxycholic Acid
1
Telemedicine
1
Suppositories
1
Selenium
1
Radiotherapy
1
Propofol
1
Ofloxacin
1
Midazolam
1
Methods
1
Folic Acid
1
Fentanyl
1
Fatty Acids, Omega-3
1
Everolimus
1
Endoscopic Mucosal Resection
1
Endomet
1
Doxycycline
1
Diet
1
Diagnosis
1
Cholecalciferol
1
Celecoxib
1
Calcium Carbonate
1
CVD protocol
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polyps
×
Fatty Acids, Omega-3
×
Clear all
NCT03661047
2021-11-17
OMICC
Massachusetts General Hospital
Phase 2
Withdrawn